𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum, Pleural Effusion, and Ascites CA-125 Levels in Ovarian Cancer and Nonovarian Benign and Malignant Diseases: A Comparative Study

✍ Scribed by Omer Topalak; Ugur Saygili; Mujde Soyturk; Nurtac Karaca; Yucel Batur; Turhan Uslu; Oktay Erten

Book ID
112248849
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
61 KB
Volume
85
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Lipoprotein(a) and CA125 levels in the p
Lipoprotein(a) and CA125 levels in the plasma of patients with benign and malignant ovarian disease
✍ Annette C. Kuesel; ThΓ©rΓ¨se Kroft; Michel PrΓ©fontaine; Ian C. P. Smith πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 French βš– 690 KB

## Abstract Elevated plasma levels of apolipoprotein (a) have been reported earlier in cancer patients. In order to investigate the potential of apolipoprotein(a) as an ovarian tumour marker, plasma apolipoprotein(a) and CA125 levels were measured in healthy women and women with benign or malignant

Association between serum levels of solu
Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy : A Gynecologic Oncology Group study
✍ Robert A. Burger; Kathleen M. Darcy; Philip J. DiSaia; Bradley J. Monk; Elizabet πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 209 KB πŸ‘ 1 views

## Abstract ## BACKGROUND A prospective study was undertaken within the Gynecologic Oncology Group to determine whether serum levels of soluble tumor necrosis factor receptors I (sTNFR‐I) and II (sTNFR‐II), alone or in combination with CA 125, were associated with clinicopathologic characteristics